Back to shop

Ludipress® LCE

0.00

Clear
-
+

Total:

Description

Ludipress® LCE is a ready-to-use direct compression solution for lozenges, chewables and effervescent tablet. The white, free-flowin granulate that means quicker, easier, and more cost-effective tableting. With Ludipress® LCE, you save precious time on developing, analyzing and blending. You simply add your active ingredient, a lubricant, and compress your tablets. It is that easy.

Ludipress® LCE means less effort, lower costs, and higher quality for lozenges, chewables, sublingual or effervescent tablets and modified release formulations. Ludipress® LCE does – in contrast to Ludipress® – not contain the disintegrant Kollidon® CL. Ludipress® LCE is therefore completely water-soluble and particularly suitable for the cost saving direct compression of processing. It enables direct compression of the majority of tablets that do not require a disintegrant. Like Ludipress®, Ludipress® LCE is a granulate that forms a homogenous mixture with the active ingredient – saving you development and analysis costs, and enabling you to quickly achieve the perfect formulation. When disintegrant Kollidon® CL is admixed, Ludipress® LCE is also suitable for all other kinds of tablets. When combined with an additional dry binder in the shape of Kollidon® VA 64, Ludipress® LCE can also be employed for high-dosage formulations.

Ludipress® LCE – enabling efficient direct tablet manufacturing

  • Streamlines the production process, reducing complexity and effort like no other direct-tableting excipient
  • Completely water-soluble
  • Outstanding binding power
  • Excellent flowability and ideal particle size distribution
  • Produces tablets of exceptional hardness
  • Accelerates product development
Ludipress® LCE composition 96.5% Lactose + 3.5% Kollidon® 30

The result: a granulate comprising carrier and filler as well as a tried and tested Povidone binder, with superior binding power.

Additional information

Manufacturer

BASF

Quality

JP, Ph.Eur., USP/NF

Cas-No

5989-81-1, 9003-39-8

Composition

Kollidon® 30, Lactose Monohydrate, Povidone

Dosage Form

Chewable tablets, Effervescent tablets, Lozenges, modified release formulations

Function

Bulking agent, Direct compression

Documents and Links

BASF Product Overview

Download

You may also like…

Kollidon® 25

0.00
BASF Select options

Kollidon® 30 LP

0.00
BASF Select options

Kollidon® VA 64 Fine

0.00
BASF Select options